Lyme Disease
📧 Sign up to get email alerts when something new happens for Lyme Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age [Phase 1, Phase 2]
Phase 1/2 study evaluating safety and immunogenicity of mRNA-1975 and mRNA-1982 for Lyme disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) [Phase 3]
Phase 3 trial assessing efficacy, safety, tolerability, immunogenicity, and lot-consistency of a 6-valent OspA-based Lyme disease vaccine (V…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults [Phase 3]
Pfizer is conducting a Phase 3 trial to study different dosing schedules of a Lyme disease vaccine (VLA15) in healthy adults. The study is c…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Searching for Persistence of Infection in Lyme Disease [EARLY_Phase 1]
This clinical trial update indicates that an early-phase 1 study sponsored by the National Institute of Allergy and Infectious Diseases on t…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
This entry describes ongoing recruitment for a study evaluating clinical, microbiological, and immunological aspects of patients with suspec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine [Phase 3]
A Phase 3 clinical trial update examining the safety, tolerability, and immunogenicity of a fifth dose of Pfizer's 6-Valent OspA-based Lyme …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Different Amoxicillin Treatment Regimens in Erythema Migrans Patients [Phase 3]
A Phase 3 trial from University Medical Centre Ljubljana is evaluating different amoxicillin regimens for erythema migrans and is currently …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
This clinical-trial update describes ongoing evaluation, treatment, and follow-up for Lyme disease. It notes that the study is currently rec…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
This multicenter French trial investigates disseminated Borrelia infections (Lyme disease) in patients treated with anti-CD20 therapies; rec…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Symptomatic Management of Lyme Arthritis [Phase 3]
Phase 3 trial investigating symptomatic management of Lyme arthritis has been terminated, with results posted.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study. [Phase 4]
Phase 4 clinical trial evaluating doxycycline-boosted therapy for Lyme disease with nervous system involvement is currently not yet recruiti…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) [Phase 3]
Pfizer's Phase 3 trial update for the 6-valent OspA-based Lyme disease vaccine VLA15 indicates the study is active but not currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children [Phase 3]
Pfizer conducted a Phase 3 safety study of a Lyme disease vaccine in healthy children; the trial has completed.
-
CLINICAL_TRIALS other · 2025-08-27Clinical Trial Update: Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis)) [Phase 4]
Phase 4 clinical trial evaluating the effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic thera…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age [Phase 1, Phase 2]
A completed Phase 1/2 study by Moderna evaluated the safety and immunogenicity of two Lyme disease vaccine candidates, mRNA-1975 and mRNA-19…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Effects of Psilocybin in Post-Treatment Lyme Disease [Phase 1]
A Phase 1 study at Johns Hopkins evaluating psilocybin for post-treatment Lyme disease syndrome has completed.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Navigating Pregnancy and Parenthood With Lyme Disease
A ClinicalTrials.gov update indicates a recruiting study examining Lyme disease during pregnancy and its implications for parenting, includi…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. [NA]
A clinical trial is evaluating whether a program combining adapted physical activity and therapeutic education improves chronic symptoms att…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy [NA]
This update outlines the safety and effectiveness assessment of the BlinkER System for facial nerve palsy conditions, including Bell's palsy…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Lyme Disease
Non-interventional pilot study investigating gut microbiota's role in Lyme disease has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Human Immune Response to Ixodes Scapularis Tick Bites [Phase 1, Phase 2]
Phase 1/2 clinical trial update assessing human immune responses to Ixodes scapularis tick bites, with recruitment ongoing.
-
FDA approval · 2025-03-31FDA Approved: DOXYCYCLINE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for doxycycline from Par Health USA, LLC under an ANDA, authorizing changes to the generic produ…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Patient's Pretreatment Expectations About Post-Lyme Symptoms [NA]
A clinical trial at University Medical Centre Ljubljana is recruiting participants with Erythema migrans to study pretreatment expectations …
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Duration of Doxycycline Treatment in MEM Patients [NA]
Clinical trial update notes a study evaluating the duration of doxycycline treatment in patients with erythema migrans (Lyme disease), with …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases [NA]
A Montpellier-based clinical trial is assessing serological exposure of professionals to multiple zoonotic pathogens, with status NOT_YET_RE…